"The Many Benefits of Coca — The 'Divine Leaf' with 8,000+ Years of Use" — Tim Ferriss

Why this is in the vault

A deep-cut episode on a largely unstudied plant with credible metabolic, cognitive, and mood benefits — the kind of peripheral health edge that sits squarely at the intersection of longevity research and performance optimization. Weil and Davis bring 60+ combined years of firsthand ethnobotanical and clinical contact.

Episode summary

Dr. Andrew Weil and ethnographer Wade Davis join Tim Ferriss to make the case for rehabilitating the coca leaf: distinguishing it from cocaine, documenting 8,000 years of safe use by Andean and Amazonian cultures, and arguing it represents one of the most promising unstudied plants in medicine. The episode covers subjective effects (mild sustained energy, mood lift, appetite suppression, no crash), pharmacological complexity (14 alkaloids, paradoxical GI effects), the racist colonial history behind its scheduling, and pragmatic next steps for research funding and policy change.

Key arguments / segments

[00:01:02] Tim opens with his personal experience: coca leaf tea resolved severe altitude sickness within hours in Chile, faster than Diamox, which framed his curiosity about the plant's mechanism.
[00:03:01] Weil traces his first encounter to 1965, sent by Harvard botanist Richard Evans Schultes; has used coca continuously since. Describes it as the Andean equivalent of peppermint/chamomile — the primary medicinal plant of the culture, used for GI disorders, energy, altitude sickness, mood, and metabolic regulation.
[00:05:00] Weil introduces the 14-alkaloid complexity: cocaine is one of 14, all structurally related, none studied individually. Once cocaine was isolated in the 19th century, research on the rest stopped entirely.
[00:06:02] Paradox of GI effects explained: coca alkaloids structurally resemble both gut stimulants and gut paralytics (atropine/scopolamine). Weil's hypothesis: the body selects which receptors to bind based on current state — a model for whole-plant vs. isolated-compound medicine.
[00:10:00] Davis contextualizes the 8,000-year record: no evidence of toxicity or addiction across all Andean and Northwest Amazon cultures. First nutritional study not done until 1975 (Plowman/Duke) — found higher calcium than any other studied plant, vitamins, proteins, and carbohydrate-metabolizing enzymes.
[00:17:01] Subjective experience compared to pharmaceutical stimulants: Ferriss distinguishes coca from modafinil and amphetamines — no dependence rebound, no crash; Wade Davis credits it for sustained creative output across 24 books and 50 films. Weil coins it "the stimulant that's not a stimulant."
[00:32:01] Priority research targets identified: GI disorders, substance abuse disorders, ADHD (safer stimulant), carbohydrate/metabolic regulation, type 2 diabetes prevention. Chris McCurdy (University of Florida, pharmacologist) named as the current lead researcher — just received his leaf supply.
[00:43:01] Weil reveals he turned 84 on the day of recording and attributes part of his health and productivity to regular coca use.
[01:06:00] Davis reads aloud the foundational 1940s WHO language that shaped current UN drug conventions — overtly racist text authored by Pablo Osvaldo Wolf, which still underlies coca's Schedule I UN classification alongside fentanyl and heroin.
[01:11:00] Ferriss flags the appetite suppression + physical vigor combination and muses about ketone measurements, framing it as an obvious and simple experiment that should have been done decades ago.

Notable claims

[00:04:01] Andean populations with high genetic risk for type 2 diabetes do not develop it when maintaining traditional diet, exercise, and coca use; they develop high rates when they move to lower altitudes and adopt Western diets — one glucose-load/exercise-bike study showed blood sugar normalization the moment chewing began.
[00:10:00] First nutritional study on coca wasn't done until 1975, despite the plant having been "demonized" since the 1920s — Davis attributes this to willful ignorance, not oversight.
[00:11:00] Coca contains more calcium than any other plant in Plowman/Duke's 1975 study.
[00:14:02] UN currently schedules coca leaf alongside fentanyl and heroin. Bolivia and Colombia both formally requested descheduling; the Vienna meeting (recent) voted to maintain the status quo.
[00:22:01] Coca was domesticated three separate times in pre-Columbian history — an almost unprecedented event in plant domestication.
[00:35:01] Ferriss suggests $50K was enough to meaningfully advance early psilocybin-depression research at Hopkins in 2015 — framing coca research as similarly accessible to individual philanthropists.
[01:03:01] The only legal coca export from Peru goes to Stepan Chemical in Maywood, NJ, which extracts cocaine for pharmaceutical use and supplies the residual extract as a secret Coca-Cola flavoring ingredient.
[00:23:01] Coca is Schedule II (not Schedule I) in the US controlled substances framework, specifically because cocaine has recognized medical applications in ophthalmology and dentistry — this makes US-based research more tractable than cannabis/psychedelics were.

Guests

Dr. Andrew Weil — Integrative medicine physician, founder of the Andrew Weil Center for Integrative Medicine at the University of Arizona (awcim.org). Has trained nearly 3,000 physicians in integrative approaches including botanical medicine. First encountered coca in 1965 under Richard Evans Schultes. Founded the Beneficial Plant Research Association (bp.org) in the 1970s, revived recently. Personal coca user for 60+ years.

Wade Davis — Canadian ethnographer, writer, photographer, and anthropologist. Author of 24 books including One River (biography of Schultes and the coca world). Made 50 documentary films. Completed the Peruvian Qoyllur Riti ritual race at 48 — the only outsider ever to do it — fueled by coca. Views rehabilitating coca as the defining work of his late career.

Mapping against Ray Data Co

Metabolic relevance (high): The blood sugar normalization claim — coca blunting post-glucose spikes in Andean subjects — is directly relevant to anyone optimizing metabolic health. Ray is on tirzepatide (Zepbound) and actively working on weight and metabolic function. The carbohydrate metabolism angle (high-starch diet + coca = no diabetes vs. same population without coca = high rates) is the kind of n-of-1 experiment that fits the RDCO self-optimization frame.

Productivity/cognitive framing (medium-high): Wade Davis's "24 books, 50 films" attribution to sustained coca use — combined with the "focus at task without feeling stimulated" description — maps cleanly to a solo founder who needs deep-work hours. The contrast with caffeine crash and modafinil rebound is practically useful. No current legal access path, which limits near-term applicability.

Gout/hydration flag (low risk, worth noting): No specific gout interaction mentioned for coca. The alkaloids are processed through the oral mucosa and GI tract, not the renal pathway where uric acid accumulates. No red flags here.

Entrepreneurial angle (peripheral): Wade Davis explicitly calls out the commercial opportunity — "the person who manages to crack this nut has the potential to make enormous wealth" and draws the matcha parallel. Not an RDCO play, but worth tracking as a category.

Research/policy: Chris McCurdy (U of Florida) is the person to watch. bp.org is the organization. Tim Ferriss is personally willing to help fund research. The Schedule II US status (vs. Schedule I for cannabis) means research pathways already exist.

[[user_health_clinical]] — gout, tirzepatide, metabolic health context
[[06-reference/ethnobotany-whole-plant-medicine]] — whole-plant vs. isolated compound framework appears repeatedly here
[[user_money_values_potential_tension]] — Ferriss framing of coca as the next matcha commercial opportunity

tim ferriss coca leaf